Global Oncology Molecular Diagnostics Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Basic Information of Oncology Molecular Diagnostics

1.1.1 Definition of Oncology Molecular Diagnostics

1.1.2 Classifications of Oncology Molecular Diagnostics

1.1.2.1 Breast Cancer

1.1.2.2 Colorectal Cancer

1.1.2.3 Prostate Cancer

1.1.2.4 Other Cancers

1.1.3 Applications of Oncology Molecular Diagnostics

1.1.4 Characteristics of Oncology Molecular Diagnostics

1.2 Development Overview of Oncology Molecular Diagnostics

1.3 Enter Barriers Analysis of Oncology Molecular Diagnostics

2 Oncology Molecular Diagnostics International and China Market Analysis

2.1 Oncology Molecular Diagnostics Industry International Market Analysis

2.1.1 Oncology Molecular Diagnostics International Market Development History

2.1.2 Oncology Molecular Diagnostics Competitive Landscape Analysis

2.1.3 Oncology Molecular Diagnostics International Main Countries Development Status

2.1.4 Oncology Molecular Diagnostics International Market Development Trend

2.2 Oncology Molecular Diagnostics Industry China Market Analysis

2.2.1 Oncology Molecular Diagnostics China Market Development History

2.2.2 Oncology Molecular Diagnostics Competitive Landscape Analysis

2.2.3 Oncology Molecular Diagnostics China Main Regions Development Status

2.2.4 Oncology Molecular Diagnostics China Market Development Trend

2.3 Oncology Molecular Diagnostics International and China Market Comparison Analysis

3 Environment Analysis of Oncology Molecular Diagnostics

3.1 International Economy Analysis

3.2 China Economy Analysis

3.3 Policy Analysis of Oncology Molecular Diagnostics

3.4 News Analysis of Oncology Molecular Diagnostics

4 Analysis of Revenue by Classifications

4.1 Global Revenue of Oncology Molecular Diagnostics by Classifications 2011-2016

4.2 Global Revenue Growth Rate of Oncology Molecular Diagnostics by Classifications 2011-2016

4.3 Oncology Molecular Diagnostics Revenue by Classifications

5 Analysis of Revenue by Regions and Applications

5.1 Global Revenue of Oncology Molecular Diagnostics by Regions 2011-2016

5.2 2011-2016 USA Revenue and Revenue Growth Rate of Oncology Molecular Diagnostics

5.3 2011-2016 Europe Revenue and Revenue Growth Rate of Oncology Molecular Diagnostics

5.4 2011-2016 Japan Revenue and Revenue Growth Rate of Oncology Molecular Diagnostics

5.5 2011-2016 China Revenue and Revenue Growth Rate of Oncology Molecular Diagnostics

6 Analysis of Oncology Molecular Diagnostics Revenue Market Status 2011-2016

6.1 Revenue of Oncology Molecular Diagnostics 2011-2016

6.2 Revenue Market Share Analysis of Oncology Molecular Diagnostics 2011-2016

6.3 Revenue Overview of Oncology Molecular Diagnostics 2011-2016

6.4 Gross Margin of Oncology Molecular Diagnostics 2011-2016

7 Analysis of Oncology Molecular Diagnostics Industry Key Manufacturers

7.1 Abbott Diagnostics

7.1.1 Company Profile

7.1.2 Revenue and Gross Margin

7.1.3 Abbott Diagnostics SWOT Analysis

7.2 Becton.Dickinson and Company

7.2.1 Company Profile

7.2.2 Revenue and Gross Margin

7.2.3 Becton.Dickinson and Company SWOT Analysis

7.3 QIAGEN

7.3.1 Company Profile

7.3.2 Revenue and Gross Margin

7.3.3 QIAGEN SWOT Analysis

7.4 Roche Diagnostics

7.4.1 Company Profile

7.4.2 Revenue and Gross Margin

7.4.3 Roche Diagnostics SWOT Analysis

7.5 Agendia

7.5.1 Company Profile

7.5.2 Revenue and Gross Margin

7.5.3 Agendia SWOT Analysis

7.6 Angsana Molecular and Diagnostics

7.6.1 Company Profile

7.6.2 Revenue and Gross Margin

7.6.3 Angsana Molecular and Diagnostics SWOT Analysis

7.7 Asuragen

7.7.1 Company Profile

7.7.2 Revenue and Gross Margin

7.7.3 Asuragen SWOT Analysis

7.8 Autogenomics

7.8.1 Company Profile

7.8.2 Revenue and Gross Margin

7.8.3 Autogenomics SWOT Analysis

7.9 Beckman Coulter

7.9.1 Company Profile

7.9.2 Revenue and Gross Margin

7.9.3 Beckman Coulter SWOT Analysis

7.10 BioMerieux

7.10.1 Company Profile

7.10.2 Revenue and Gross Margin

7.10.3 BioMerieux SWOT Analysis

7.11 Cangen Biotechnologies

7.11.1 Company Profile

7.11.2 Revenue and Gross Margin

7.11.3 Cangen Biotechnologies SWOT Analysis

7.12 Cepheid

7.12.1 Company Profile

7.12.2 Revenue and Gross Margin

7.12.3 Cepheid SWOT Analysis

7.13 Diagnocure

7.13.1 Company Profile

7.13.2 Revenue and Gross Margin

7.13.3 Diagnocure SWOT Analysis

7.14 Epigenomics

7.14.1 Company Profile

7.14.2 Revenue and Gross Margin

7.14.3 Epigenomics SWOT Analysis

7.15 Eragen

7.15.1 Company Profile

7.15.2 Revenue and Gross Margin

7.15.3 Eragen SWOT Analysis

7.16 EXACT Sciences

7.16.1 Company Profile

7.16.2 Revenue and Gross Margin

7.16.3 EXACT Sciences SWOT Analysis

7.17 Exiqon

7.17.1 Company Profile

7.17.2 Revenue and Gross Margin

7.17.3 Exiqon SWOT Analysis

7.18 GeneNews

7.18.1 Company Profile

7.18.2 Revenue and Gross Margin

7.18.3 GeneNews SWOT Analysis

7.19 Genera Biosystems

7.19.1 Company Profile

7.19.2 Revenue and Gross Margin

7.19.3 Genera Biosystems SWOT Analysis

7.20 Genomic Health

7.20.1 Company Profile

7.20.2 Revenue and Gross Margin

7.20.3 Genomic Health SWOT Analysis

7.21 Genomix Biotech

7.21.1 Company Profile

7.21.2 Revenue and Gross Margin

7.21.3 Genomix Biotech SWOT Analysis

7.22 Health Discovery

7.22.1 Company Profile

7.22.2 Revenue and Gross Margin

7.22.3 Health Discovery SWOT Analysis

7.23 HTG Molecular

7.23.1 Company Profile

7.23.2 Revenue and Gross Margin

7.23.3 HTG Molecular SWOT Analysis

7.24 Hologic

7.24.1 Company Profile

7.24.2 Revenue and Gross Margin

7.24.3 Hologic SWOT Analysis

7.25 Innogenetics

7.25.1 Company Profile

7.25.2 Revenue and Gross Margin

7.25.3 Innogenetics SWOT Analysis

7.26 Intergenetics

7.26.1 Company Profile

7.26.2 Revenue and Gross Margin

7.26.3 Intergenetics SWOT Analysis

7.27 Kreatech Holding

7.27.1 Company Profile

7.27.2 Revenue and Gross Margin

7.27.3 Kreatech Holding SWOT Analysis

7.28 Myriad Genetics

7.28.1 Company Profile

7.28.2 Revenue and Gross Margin

7.28.3 Myriad Genetics SWOT Analysis

7.29 Nanosphere

7.29.1 Company Profile

7.29.2 Revenue and Gross Margin

7.29.3 Nanosphere SWOT Analysis

7.30 NorDiag

7.30.1 Company Profile

7.30.2 Revenue and Gross Margin

7.30.3 NorDiag SWOT Analysis

7.31 Nuvera Biosciences

7.31.1 Company Profile

7.31.2 Revenue and Gross Margin

7.31.3 Nuvera Biosciences SWOT Analysis

7.32 OncoMethylome Sciences

7.32.1 Company Profile

7.32.2 Revenue and Gross Margin

7.32.3 OncoMethylome Sciences SWOT Analysis

7.33 Orion Genomics

7.33.1 Company Profile

7.33.2 Revenue and Gross Margin

7.33.3 Orion Genomics SWOT Analysis

7.34 Prediction Sciences

7.34.1 Company Profile

7.34.2 Revenue and Gross Margin

7.34.3 Prediction Sciences SWOT Analysis

7.35 Predictive Biosciences

7.35.1 Company Profile

7.35.2 Revenue and Gross Margin

7.35.3 Predictive Biosciences SWOT Analysis

7.36 Rosetta Genomics

7.36.1 Company Profile

7.36.2 Revenue and Gross Margin

7.36.3 Rosetta Genomics SWOT Analysis

7.37 SensiGen

7.37.1 Company Profile

7.37.2 Revenue and Gross Margin

7.37.3 SensiGen SWOT Analysis

7.38 Source MDx

7.38.1 Company Profile

7.38.2 Revenue and Gross Margin

7.38.3 Source MDx SWOT Analysis

7.39 Vermillion

7.39.1 Company Profile

7.39.2 Revenue and Gross Margin

7.39.3 Vermillion SWOT Analysis

8 Sales Price and Gross Margin Analysis

8.1 Sales Price Analysis of Oncology Molecular Diagnostics

8.2 Gross Margin Analysis of Oncology Molecular Diagnostics

9 Marketing Trader or Distributor Analysis of Oncology Molecular Diagnostics

9.1 Marketing Channels Status of Oncology Molecular Diagnostics

9.2 How Countries Meet Their Needs

9.2.1 USA

9.2.2 China

9.2.3 Japan

9.2.4 Germany

10 Development Trend of Oncology Molecular Diagnostics Industry 2016-2021

10.1 Revenue Overview of Oncology Molecular Diagnostics 2016-2021

10.2 Sales Price Overview of Oncology Molecular Diagnostics 2016-2021

11 Industry Chain Suppliers of Oncology Molecular Diagnostics with Contact Information

11.1 Equipment Suppliers of Oncology Molecular Diagnostics with Contact Information

11.2 Major Suppliers of Oncology Molecular Diagnostics with Contact Information

11.3 Key Consumers of Oncology Molecular Diagnostics with Contact Information

11.4 Supply Chain Relationship Analysis of Oncology Molecular Diagnostics

12 New Project Investment Feasibility Analysis of Oncology Molecular Diagnostics

12.1 New Project SWOT Analysis of Oncology Molecular Diagnostics

12.2 New Project Investment Feasibility Analysis of Oncology Molecular Diagnostics

13 Conclusion of the Global Oncology Molecular Diagnostics Industry 2015 Market Research Report

Table Classifications of Oncology Molecular Diagnostics

Table Applications of Oncology Molecular Diagnostics

Table Policy of Oncology Molecular Diagnostics

Table Industry News List of Oncology Molecular Diagnostics

Table Global Revenue of Oncology Molecular Diagnostics by Classifications 2011-2016 (M USD)

Table Global Revenue Market Share of Oncology Molecular Diagnostics by Classifications 2011-2016

Figure Global Revenue Market Share of Oncology Molecular Diagnostics by Classifications in 2011

Figure Global Revenue Market Share of Oncology Molecular Diagnostics by Classifications in 2015

Figure Global Revenue Growth Rate of Type One 2011-2016

Figure Global Revenue Growth Rate of Type Two 2011-2016

Figure Global Revenue Growth Rate of Type Three 2011-2016

Table USA Oncology Molecular Diagnostics Revenue by Classifications

Table Europe Oncology Molecular Diagnostics Revenue by Classifications

Table Japan Oncology Molecular Diagnostics Revenue by Classifications

Table China Oncology Molecular Diagnostics Revenue by Classifications

Table Global Revenue of Oncology Molecular Diagnostics by Regions 2011-2016 (M USD)

Table Global Revenue Market Share of Oncology Molecular Diagnostics by Regions 2011-2016

Figure Global Revenue Market Share of Oncology Molecular Diagnostics by Regions in 2011

Figure Global Revenue Market Share of Oncology Molecular Diagnostics by Regions in 2015

Figure USA Oncology Molecular Diagnostics Revenue by Applications

Figure USA Oncology Molecular Diagnostics Revenue and Revenue Growth Rate

Figure Europe Oncology Molecular Diagnostics Revenue by Applications

Figure Europe Oncology Molecular Diagnostics Revenue and Revenue Growth Rate

Figure Japan Oncology Molecular Diagnostics Revenue by Applications

Figure Japan Oncology Molecular Diagnostics Revenue and Revenue Growth Rate

Figure China Oncology Molecular Diagnostics Revenue by Applications

Figure China Oncology Molecular Diagnostics Revenue and Revenue Growth Rate

Table Global and China Major Players Oncology Molecular Diagnostics Revenue of 2011-2016 (M USD)

Table Global and China Major Players Oncology Molecular Diagnostics Revenue Market Share of 2011-2016

Table China Major Players Oncology Molecular Diagnostics Revenue of 2011-2016 (M USD)

Table China Major Players Oncology Molecular Diagnostics Revenue Market Share of 2011-2016

Figure Global Revenue Market Share of Major Oncology Molecular Diagnostics Players in 2011

Figure Global Revenue Market Share of Major Oncology Molecular Diagnostics Players in 2015

Figure China Revenue Market Share Major Oncology Molecular Diagnostics Players in 2011

Figure China Revenue Market Share Major Oncology Molecular Diagnostics Players in 2015

Figure Global Revenue and Growth Rate of Oncology Molecular Diagnostics 2011-2016

Figure China Revenue and Growth Rate of Oncology Molecular Diagnostics 2011-2016

Figure 2011-2016 Global and China Oncology Molecular Diagnostics Revenue Comparison

Table Cost of Global Oncology Molecular Diagnostics Major Players 2011-2016 (M USD)

Table Gross of Global Oncology Molecular Diagnostics Major Players 2011-2016 (M USD)

Table Gross Margin of Global Oncology Molecular Diagnostics Major Players 2011-2016

Figure Gross Margin of Global Oncology Molecular Diagnostics Major Players in 2015

Table Company Profile List of Abbott Diagnostics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Abbott Diagnostics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Abbott Diagnostics 2011-2016

Table SWOT Analysis of Abbott Diagnostics 2011-2016

Table Company Profile List of Becton.Dickinson and Company

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Becton.Dickinson and Company 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Becton.Dickinson and Company 2011-2016

Table SWOT Analysis of Becton.Dickinson and Company 2011-2016

Table Company Profile List of QIAGEN

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of QIAGEN 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of QIAGEN 2011-2016

Table SWOT Analysis of QIAGEN 2011-2016

Table Company Profile List of Roche Diagnostics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Roche Diagnostics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Roche Diagnostics 2011-2016

Table SWOT Analysis of Roche Diagnostics 2011-2016

Table Company Profile List of Agendia

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agendia 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Agendia 2011-2016

Table SWOT Analysis of Agendia 2011-2016

Table Company Profile List of Angsana Molecular and Diagnostics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Angsana Molecular and Diagnostics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Angsana Molecular and Diagnostics 2011-2016

Table SWOT Analysis of Angsana Molecular and Diagnostics 2011-2016

Table Company Profile List of Asuragen

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Asuragen 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Asuragen 2011-2016

Table SWOT Analysis of Asuragen 2011-2016

Table Company Profile List of Autogenomics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Autogenomics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Autogenomics 2011-2016

Table SWOT Analysis of Autogenomics 2011-2016

Table Company Profile List of Beckman Coulter

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Beckman Coulter 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Beckman Coulter 2011-2016

Table SWOT Analysis of Beckman Coulter 2011-2016

Table Company Profile List of BioMerieux

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of BioMerieux 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of BioMerieux 2011-2016

Table SWOT Analysis of BioMerieux 2011-2016

Table Company Profile List of Cangen Biotechnologies

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Cangen Biotechnologies 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Cangen Biotechnologies 2011-2016

Table SWOT Analysis of Cangen Biotechnologies 2011-2016

Table Company Profile List of Cepheid

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Cepheid 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Cepheid 2011-2016

Table SWOT Analysis of Cepheid 2011-2016

Table Company Profile List of Diagnocure

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Diagnocure 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Diagnocure 2011-2016

Table SWOT Analysis of Diagnocure 2011-2016

Table Company Profile List of Epigenomics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Epigenomics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Epigenomics 2011-2016

Table SWOT Analysis of Epigenomics 2011-2016

Table Company Profile List of Eragen

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Eragen 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Eragen 2011-2016

Table SWOT Analysis of Eragen 2011-2016

Table Company Profile List of EXACT Sciences

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of EXACT Sciences 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of EXACT Sciences 2011-2016

Table SWOT Analysis of EXACT Sciences 2011-2016

Table Company Profile List of Exiqon

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Exiqon 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Exiqon 2011-2016

Table SWOT Analysis of Exiqon 2011-2016

Table Company Profile List of GeneNews

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of GeneNews 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of GeneNews 2011-2016

Table SWOT Analysis of GeneNews 2011-2016

Table Company Profile List of Genera Biosystems

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Genera Biosystems 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Genera Biosystems 2011-2016

Table SWOT Analysis of Genera Biosystems 2011-2016

Table Company Profile List of Genomic Health

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Genomic Health 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Genomic Health 2011-2016

Table SWOT Analysis of Genomic Health 2011-2016

Table Company Profile List of Genomix Biotech

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Genomix Biotech 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Genomix Biotech 2011-2016

Table SWOT Analysis of Genomix Biotech 2011-2016

Table Company Profile List of Health Discovery

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Health Discovery 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Health Discovery 2011-2016

Table SWOT Analysis of Health Discovery 2011-2016

Table Company Profile List of HTG Molecular

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of HTG Molecular 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of HTG Molecular 2011-2016

Table SWOT Analysis of HTG Molecular 2011-2016

Table Company Profile List of Hologic

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Hologic 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Hologic 2011-2016

Table SWOT Analysis of Hologic 2011-2016

Table Company Profile List of Innogenetics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Innogenetics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Innogenetics 2011-2016

Table SWOT Analysis of Innogenetics 2011-2016

Table Company Profile List of Intergenetics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Intergenetics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Intergenetics 2011-2016

Table SWOT Analysis of Intergenetics 2011-2016

Table Company Profile List of Kreatech Holding

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Kreatech Holding 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Kreatech Holding 2011-2016

Table SWOT Analysis of Kreatech Holding 2011-2016

Table Company Profile List of Myriad Genetics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Myriad Genetics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Myriad Genetics 2011-2016

Table SWOT Analysis of Myriad Genetics 2011-2016

Table Company Profile List of Nanosphere

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Nanosphere 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Nanosphere 2011-2016

Table SWOT Analysis of Nanosphere 2011-2016

Table Company Profile List of NorDiag

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of NorDiag 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of NorDiag 2011-2016

Table SWOT Analysis of NorDiag 2011-2016

Table Company Profile List of Nuvera Biosciences

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Nuvera Biosciences 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Nuvera Biosciences 2011-2016

Table SWOT Analysis of Nuvera Biosciences 2011-2016

Table Company Profile List of OncoMethylome Sciences

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of OncoMethylome Sciences 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of OncoMethylome Sciences 2011-2016

Table SWOT Analysis of OncoMethylome Sciences 2011-2016

Table Company Profile List of Orion Genomics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Orion Genomics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Orion Genomics 2011-2016

Table SWOT Analysis of Orion Genomics 2011-2016

Table Company Profile List of Prediction Sciences

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Prediction Sciences 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Prediction Sciences 2011-2016

Table SWOT Analysis of Prediction Sciences 2011-2016

Table Company Profile List of Predictive Biosciences

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Predictive Biosciences 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Predictive Biosciences 2011-2016

Table SWOT Analysis of Predictive Biosciences 2011-2016

Table Company Profile List of Rosetta Genomics

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Rosetta Genomics 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Rosetta Genomics 2011-2016

Table SWOT Analysis of Rosetta Genomics 2011-2016

Table Company Profile List of SensiGen

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of SensiGen 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of SensiGen 2011-2016

Table SWOT Analysis of SensiGen 2011-2016

Table Company Profile List of Source MDx

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Source MDx 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Source MDx 2011-2016

Table SWOT Analysis of Source MDx 2011-2016

Table Company Profile List of Vermillion

Table Oncology Molecular Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Vermillion 2011-2016

Figure Oncology Molecular Diagnostics Revenue and Growth Rate of Vermillion 2011-2016

Table SWOT Analysis of Vermillion 2011-2016

Figure Oncology Molecular Diagnostics Manufactor Profit Model

Figure Marketing Channels Status of Oncology Molecular Diagnostics

Figure Global Revenue and Growth Rate of Oncology Molecular Diagnostics 2016-2021

Figure China Revenue and Growth Rate of Oncology Molecular Diagnostics 2016-2021

Figure Global and China Oncology Molecular Diagnostics Revenue Comparison 2016-2021

Table Equipment Suppliers of Oncology Molecular Diagnostics with Contact Information

Table Major Suppliers of Oncology Molecular Diagnostics with Contact Information

Table Key Consumers of Oncology Molecular Diagnostics with Contact Information

Figure Supply Chain Relationship Analysis of Oncology Molecular Diagnostics

Table New Project SWOT Analysis of Oncology Molecular Diagnostics